neurology
Hoehn & Yahr Staging for Parkinson's Disease
Original 1967 (and modified) staging of Parkinson's disease severity by motor symptoms and disability. Drives clinical decisions on therapy intensity and rehabilitation.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Ropinirole · Dopamine Agonist — Parkinson's Disease
- Entacapone · COMT Inhibitor — Parkinson's Disease
- Rasagiline · MAO-B Inhibitor — Parkinson's Disease
- Trihexyphenidyl · Anticholinergic — Parkinson's Disease / Dystonia
- Apomorphine · Dopamine Agonist — Parkinson's Disease Rescue / Continuous Infusion
- Selegiline · MAO-B Inhibitor — Parkinson's Disease
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.